Friday, June 2, 2023

Partner Profiles

ARM vaccine

Defence Therapeutics’ ARM vaccine cures 100% of solid tumours in rodent models

Defence Therapeutics has revealed that the company’s cutting-edge ARM vaccine cures 100% of tumours in rodent models. The leading biopharmaceutical company revealed that performing a...

Defence Therapeutics completes AccuTOXTM preclinical efficacy studies

Defence Therapeutics has successfully completed all essential preclinical efficacy studies for the company’s AccuTOXTM programme. AccuTOXTM is one of Defence’s most advanced research and development...
trademark registration

Trademark registration approved by USPTO for DEFENCE THERAPEUTICS®

Defence Therapeutics has announced that the United States Patent and Trademark Office (USPTO) has granted registration for its trademark DEFENCE THERAPEUTICS®. This trademark is granted...

Pin It on Pinterest